| 51 |
25548514 | Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway. | 2014 |
1 |
| 52 |
23052480 | Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. | 2013 Mar |
6 |
| 53 |
23436796 | Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. | 2013 Apr 15 |
1 |
| 54 |
23665025 | Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. | 2013 May 31 |
4 |
| 55 |
23749899 | Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. | 2013 Jun |
1 |
| 56 |
22847808 | Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. | 2012 Sep 15 |
1 |
| 57 |
20958132 | Ameliorative effect of purple bamboo salt-pharmaceutical acupuncture on cisplatin-induced ototoxicity. | 2011 Jan |
1 |
| 58 |
21148032 | Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of cisplatin in mice. | 2011 Jan 15 |
1 |
| 59 |
21273582 | Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. | 2011 Jan |
6 |
| 60 |
20236757 | Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. | 2010 Sep 1 |
8 |
| 61 |
20682658 | Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinoma. | 2010 Aug |
6 |
| 62 |
20942931 | Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. | 2010 |
1 |
| 63 |
18697197 | Chemotherapeutic drugs and human tumor cells cytokine network. | 2008 Nov 1 |
1 |
| 64 |
17266043 | Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. | 2007 May 1 |
2 |
| 65 |
17516123 | Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. | 2007 Sep |
1 |
| 66 |
16525642 | Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. | 2006 Apr |
1 |
| 67 |
12447990 | Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. | 2003 Jan |
4 |
| 68 |
12729367 | Cisplatin treatment triggers familial Mediterranean fever attacks. | 2003 Jan-Feb |
1 |
| 69 |
11885806 | The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells. | 2002 |
1 |
| 70 |
11942326 | N-acetyl-L-cysteine enhances chemotherapeutic effect on prostate cancer cells. | 2002 Mar |
2 |
| 71 |
12476615 | The effect of cisplatin, etoposide and quercetin on Hsp72 expression. | 2002 |
1 |
| 72 |
11593385 | The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. | 2001 Sep 13 |
1 |
| 73 |
9921985 | Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. | 1999 Jan 1 |
2 |
| 74 |
10067009 | Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell lines. | 1999 Feb |
5 |
| 75 |
10365139 | Are renal cell carcinoma cells able to modulate the cytotoxic effect of tumor infiltrating lymphocytes by secretion of interleukin-6? | 1999 Mar-Apr |
1 |
| 76 |
10366426 | Endogenous interleukin 6 conveys resistance to cis-diamminedichloroplatinum-mediated apoptosis of the K562 human leukemic cell line. | 1999 Jun 15 |
4 |
| 77 |
10403520 | Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells. | 1999 Jul 1 |
1 |
| 78 |
9538169 | Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. | 1998 May-Jun |
1 |
| 79 |
9738983 | Release of cytokines from human umbilical vein endothelial cells treated with platinum compounds in vitro. | 1998 Jul |
1 |
| 80 |
9875677 | cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro. | 1998 Dec |
1 |
| 81 |
7553641 | Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. | 1995 Oct 15 |
3 |
| 82 |
7834629 | Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. | 1995 Feb 1 |
5 |